(NP (NP (JJ Potent) (NN gene) (ADJP-COOD (ADJP (JJ regulatory)) (CC and) (ADJP (JJ antiproliferative))) (NNS activities)) (PP (IN of) (NP (NP (JJ 20-methyl) (NNS analogues)) (PP (IN of) (NP (CD 1,25) (NN dihydroxyvitamin) (NN D3))))) (. .))
(S (NP-SBJ (NP (NP (DT The) (JJ biological) (JJ active) (NN form)) (PP (IN of) (NP (NN vitamin) (NN D3)))) (, ,) (NP (NP (NN 1,25-dihydroxyvitamin) (NN D3)) (PRN (-LRB- -LRB-) (NP (NN VD)) (-RRB- -RRB-))) (, ,)) (VP (VBZ regulates) (NP (JJ cellular) (NP-COOD (NP (NN growth)) (CC and) (NP (NN differentiation))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBZ provides) (NP (DT the) (NN hormone)) (PP (IN with) (NP (DT an) (JJ interesting) (JJ therapeutic) (NN potential)))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NN hypercalcemia)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ side) (NN effect)) (, ,) (SBAR (WHNP-82 (WDT which)) (S (NP-SBJ-83 (-NONE- *T*-82)) (VP (VBZ is) (VP (VBN caused) (NP (-NONE- *-83)) (PP (IN by) (NP-LGS (NP (NP (NN VD) (POS 's)) (JJ classical) (NN action)) (, ,) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN calcium) (NN homeostasis)))))))))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBD made) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (NN VD) (NNS analogues)) (PP (IN with) (NP (ADJP (RB selectively) (VBN increased)) (NN cell) (JJ regulatory) (NNS properties))))))) (. .))
(S (NP-SBJ (NP (NNS Studies)) (PP (IN with) (NP (JJ 20-epi) (NNS analogues)))) (VP-COOD (VP (VBD pointed) (PRT (RP out)) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (DT the) (NN carbon-20) (NN position))))) (CC and) (VP (VBD led) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NN 20-methyl) (NNS derivatives)) (PP (IN of) (NP (NN VD))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (NP-SBJ-84 (NP (DT the) (JJ biological) (NNS properties)) (PP (IN of) (NP (NP (DT the) (NNS compounds) (NP-COOD (NP (NN ZK161422)) (CC and) (NP (NN ZK157202)))) (, ,) (SBAR (WHNP-85 (WDT which)) (S (NP-SBJ (-NONE- *T*-85)) (VP (VBP are) (NP-PRD (NP-COOD (NP (NN 20-methyl-) (NP (-NONE- *?*))) (CC and) (NP (NN 20-methyl-23-eneanalogues))) (, ,) (ADVP (RB respectively)))))) (, ,)))) (VP (VBP have) (VP (VBN been) (VP (VBN analyzed) (NP (-NONE- *-84)) (PP (IN in) (NN comparison) (IN with) (NP (NN VD)))))) (. .))
(S (NP-SBJ (DT Both) (NNS compounds)) (VP (VBP show) (NP (NP (NP (ADJP (ADVP (IN about) (RB 2-fold)) (JJR lower)) (NN affinity)) (PP (TO to) (NP (NP (DT the) (NN VD) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN VDR)) (-RRB- -RRB-))))) (PP (IN than) (NP (NN VD))))) (. .))
(S (ADVP (RB However)) (, ,) (S (NP-SBJ-87 (-NONE- *-86)) (VP (VBN compared) (NP (-NONE- *-87)) (PP (TO to) (NP (NN VD))))) (, ,) (NP-SBJ-86 (PRP$ their) (JJ antiproliferative) (NN effect)) (VP-COOD (VP (VBZ is) (ADJP-PRD-107 (ADVP (QP (RB up) (TO to) (RB 30-fold))) (JJR higher)) (PP-108 (IN on) (NP (JJ human) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)))) (CC and) (VP (ADJP-PRD=107 (RB even) (ADVP (RB up) (TO to) (RB 300-fold)) (JJR higher)) (PP=108 (IN on) (NP (JJ human) (NN breast) (NN cancer) (NN MCF-7) (NNS cells))))) (. .))
(S (SBAR (IN Whereas) (S (NP-SBJ-88 (NP (DT the) (JJ hypercalcemic) (NN effect)) (PP (IN for) (NP (NN ZK157202)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN increased) (NP (-NONE- *-88)) (ADVP (RB 10-fold)))))) (, ,) (NP-SBJ (NN ZK161422)) (VP (VBZ has) (NP (NP (DT the) (JJ same) (JJ calcium-mobilizing) (NN potency)) (PP (IN as) (NP (NN VD))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ-COOD (NP (NN ZK161422)) (, ,) (CONJP (CC but) (RB not)) (NP (NN ZK157202)) (, ,)) (VP (VBD showed) (NP (NP (NN preference)) (PP-COOD (PP (IN for) (NP (NP (NN gene) (NN activation)) (PP (IN from) (NP (NP (DT a) (NN promoter)) (VP (VBG carrying) (NP (NP (DT a) (NN VD) (NN response) (NN element)) (PP (IN with) (NP (NP (DT a) (JJ palindromic) (NN arrangement)) (PP (IN of) (NP (NP (CD two) (JJ hexameric) (NN receptor) (NN binding) (NNS sites)) (VP (VBN spaced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (CD 9) (NNS nucleotides)) (PRN (-LRB- -LRB-) (NP (NN IP9)) (-RRB- -RRB-))))))))))))))) (CONJP (RB rather) (IN than)) (PP (IN for) (NP (NP (NN activation)) (PP (IN from) (NP (NP (DT a) (NN response) (NN element)) (VP (VBN formed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT a) (JJ direct) (NN repeat)) (VP (VBN spaced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (CD 3) (NNS nucleotides))))) (PRN (-LRB- -LRB-) (NP (NN DR3)) (-RRB- -RRB-)))))))))))) (. .))
(S (NP-SBJ (DT This) (NN observation)) (VP (VBZ supports) (NP (NP (DT a) (NN model)) (, ,) (SBAR (WHPP-89 (IN in) (WHNP (WDT which))) (S (NP-SBJ (NN promoter) (NN selectivity)) (VP (VBZ reflects) (NP (NP (DT the) (ADJP (RB selectively) (VBN increased)) (JJ antiproliferative) (NN effect)) (PP (IN of) (NP (NN VD) (NNS analogues)))) (PP (-NONE- *T*-89))))))) (. .))
